Adaptive Biotechnologies beats estimates with Q3 revenue of $26.1M as shares rise 6% Adaptive Biotechnologies‘ stock rose 6 percent to $30 per share in after-hours trading on Tuesday after the company reported higher… Read More
Canadian biotech company Chinook Therapeutics raises $65M for rare kidney disease therapies Chinook Therapeutics, a Vancouver, B.C.-based biotech company creating targeted therapies for kidney diseases, raised $65 million in a Series A… Read More
